Predictive factors associated with virological response in Ombitasvir/Paritaprevir/Ritonavir/Ribavirin combination therapy for genotype2a infected chronic hepatitis C patients
Not Applicable
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000026640
- Lead Sponsor
- ipppon Medical School Chiba Hokusoh Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 98
Inclusion Criteria
Not provided
Exclusion Criteria
1History of allergy to Ombitasvir/Paritaprevir /Ritonavir/Ribavirin 2Liver cirrhosis 3Patients with creatinine clearance less than 50 ml / min 4Pregnant woman or lactating mother 5Hepatocellular carcinoma, or other malignant tumor 6Judged by investigator not to be appropriate for inclusion in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method